Filament Health Corp.
FH
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 876.26% | -82.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 876.26% | -82.67% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 876.26% | -82.67% | |||
| SG&A Expenses | 84.21% | -4.77% | |||
| Depreciation & Amortization | -2.27% | 1.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 64.33% | -10.05% | |||
| Operating Income | -46.81% | 1.12% | |||
| Income Before Tax | -105.07% | 5.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -105.07% | 5.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -105.07% | 5.04% | |||
| EBIT | -46.81% | 1.12% | |||
| EBITDA | -47.94% | 1.18% | |||
| EPS Basic | -100.00% | 17.65% | |||
| Normalized Basic EPS | -35.29% | 19.05% | |||
| EPS Diluted | -100.00% | 17.65% | |||
| Normalized Diluted EPS | -35.29% | 19.05% | |||
| Average Basic Shares Outstanding | 2.16% | 16.39% | |||
| Average Diluted Shares Outstanding | 2.16% | 16.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||